Years of notes, letters and laboratory read into five lines with their sources

Visit notes, laboratory reports, imaging, external letters and the medication list become one short history, every line citing the document it came from. What happened since the last visit, and where the chart mentions a detail, is one question further.

Step 1

AKAnna Keller, 47 · Hypertension, prediabetes, LDL 162 mg/dl · 14 documents, read 16 September 2026

Summarize her history in five lines, with the sources.

Answered on 16 September 2026

Finished thinking

Patient record14 documents, updated 16 September 2026

Anna Keller, 47, teacher, BMI 27.4, former smoker (10 pack-years, stopped 2019). Intake 20.09.2023 Visit 12.05.2026
Arterial hypertension since September 2023 on ramipril 5 mg; home mean 136/86 mmHg last week, office 142/90 today. Intake 20.09.2023 BP log 15.09.2026 Visit 16.09.2026
Cardiovascular risk: LDL 162 mg/dl, non-HDL 186 mg/dl, lipoprotein(a) never measured; father with myocardial infarction at 58; simvastatin 20 mg stopped in March 2024 for myalgia with a CK of 210 U/l. Lab 08.05.2026 Intake 20.09.2023 Visit 14.03.2024
Prediabetes: HbA1c 5.9 % (May 2026), fasting glucose 104 mg/dl, mother with type 2 diabetes; mild hepatic steatosis on ultrasound, ALT 41 U/l. Lab 08.05.2026 Ultrasound 12.05.2026 Intake 20.09.2023
Other: generalised anxiety on sertraline 50 mg since 2025; vitamin D 21 ng/ml; eGFR 92, TSH normal. Medication 16.09.2026 Lab 08.05.2026

Open items are listed under “Which findings are still open?”; today's decisions are in the draft visit note. Visit 16.09.2026

See the full response

Step 2

AKAnna Keller, 47 · Hypertension, prediabetes, LDL 162 mg/dl · 14 documents, read 16 September 2026

What happened since her last visit?

Answered on 16 September 2026

Finished thinking

Since the check-up discussion on 12 May 2026, three things arrived in the chart and one visit is in progress:

Laboratory results of 8 May, discussed on 12 May: LDL 162 mg/dl, HbA1c 5.9 % (up from 5.6 % in November 2023), ALT 41 U/l, vitamin D 21 ng/ml; the ultrasound on the same day showed mild hepatic steatosis. Lab 08.05.2026 Ultrasound 12.05.2026 Visit 12.05.2026
Home blood pressure log, 9 to 15 September: mean 136/86 mmHg over 28 readings, highest 148/92. BP log 15.09.2026
Today, 16 September: office blood pressure 142/90, fatigue for three months, no chest pain or dyspnoea; she asked about her cardiovascular risk after her father's myocardial infarction at 58. The ambient note is a draft awaiting your review. Ambient note 16.09.2026 Visit 16.09.2026

Nothing else was added: no new medication, no external reports, no hospital contact. The tetanus-diphtheria booster recommended in May is still open. Medication 16.09.2026 Vaccinations 20.09.2023

See the full response

Step 3

AKAnna Keller, 47 · Hypertension, prediabetes, LDL 162 mg/dl · 14 documents, read 16 September 2026

Where does the chart mention her father's heart attack?

Answered on 16 September 2026

Finished thinking

In two places. The intake interview of 20 September 2023 records under family history: “Father: myocardial infarction at 58, stent, alive. Mother: type 2 diabetes, hypertension.” Intake 20.09.2023 The draft of today's ambient note records that she raised the topic herself: “worried since my father's heart attack, he was 58.” Ambient note 16.09.2026

The May check-up documentation does not repeat the family history, and the SCORE2 documented there was calculated without it; SCORE2 does not include family history, which is why the guideline treats a premature family history as a risk modifier on top of the score. A myocardial infarction in a first-degree male relative before 55 counts as premature; at 58 it is borderline and still worth weighing. Check-up 12.05.2026 Eur Heart J + 1

See the full response